Wednesday, December 28, 2016

BRIEF-Achillion announces clinical milestone for the advancement of JNJ-4178

* Achillion announces clinical milestone for the advancement

of JNJ-4178 in phase 2B development for chronic HCV

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)